Ken Griffin Icu Medical Inc Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Icu Medical Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 700 shares of ICUI stock, worth $126,903. This represents 0.0% of its overall portfolio holdings.

Number of Shares

700

Previous 800 12.5%

Holding current value

$126,903

Previous $85,000 2.35%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$94.53 - $120.55 $1.43 Million - $1.82 Million	15,088 Added 7.91%	205,829 $24.4 Million
Q1 2024 May 15, 2024	BUY	$86.88 - $112.48 $7.18 Million - $9.3 Million	82,693 Added 76.53%	190,741 $20.5 Million
Q4 2023 Feb 14, 2024	BUY	$81.08 - $119.29 $8.46 Million - $12.4 Million	104,345 Added 2817.85%	108,048 $10.8 Million
Q3 2023 Nov 14, 2023	BUY	$115.27 - $182.23 $404,021 - $638,716	3,505 Added 1770.2%	3,703 $440,000
Q2 2023 Aug 14, 2023	BUY	$161.03 - $209.15 $31,883 - $41,411	198 New	198 $35,000
Q2 2022 Aug 15, 2022	BUY	$161.4 - $229.7 $996,322 - $1.42 Million	6,173 Added 104.05%	12,106 $1.99 Million
Q1 2022 May 16, 2022	SELL	$203.51 - $247.46 $15.9 Million - $19.3 Million	-77,908 Reduced 92.92%	5,933 $1.32 Million
Q4 2021 Feb 14, 2022	BUY	$220.96 - $247.44 $2.99 Million - $3.35 Million	13,530 Added 19.24%	83,841 $19.9 Million
Q3 2021 Nov 15, 2021	SELL	$186.8 - $260.0 $26 Million - $36.2 Million	-139,178 Reduced 66.44%	70,311 $16.4 Million
Q2 2021 Aug 16, 2021	BUY	$190.83 - $215.73 $5.18 Million - $5.85 Million	27,125 Added 14.87%	209,489 $43.1 Million
Q1 2021 May 17, 2021	BUY	$197.58 - $222.54 $17.6 Million - $19.8 Million	89,115 Added 95.57%	182,364 $37.5 Million
Q4 2020 Feb 16, 2021	BUY	$177.6 - $214.65 $13.4 Million - $16.2 Million	75,506 Added 425.55%	93,249 $20 Million
Q3 2020 Nov 16, 2020	SELL	$177.7 - $200.24 $1.49 Million - $1.67 Million	-8,361 Reduced 32.03%	17,743 $3.24 Million
Q2 2020 Aug 14, 2020	SELL	$172.31 - $230.89 $80.3 Million - $108 Million	-466,204 Reduced 94.7%	26,104 $4.81 Million
Q1 2020 May 15, 2020	BUY	$160.04 - $216.15 $9.75 Million - $13.2 Million	60,938 Added 14.13%	492,308 $99.3 Million
Q4 2019 Feb 14, 2020	BUY	$151.88 - $189.51 $26.7 Million - $33.3 Million	175,629 Added 68.67%	431,370 $80.7 Million
Q3 2019 Nov 14, 2019	BUY	$154.21 - $257.38 $37.3 Million - $62.2 Million	241,707 Added 1722.3%	255,741 $40.8 Million
Q2 2019 Aug 14, 2019	BUY	$212.8 - $251.91 $1.91 Million - $2.26 Million	8,955 Added 176.31%	14,034 $3.54 Million
Q1 2019 May 15, 2019	SELL	$221.09 - $253.28 $4.59 Million - $5.26 Million	-20,757 Reduced 80.34%	5,079 $0
Q4 2018 Feb 14, 2019	SELL	$213.13 - $281.01 $7.37 Million - $9.72 Million	-34,589 Reduced 57.24%	25,836 $5.93 Million
Q3 2018 Nov 13, 2018	BUY	$265.5 - $307.63 $9.37 Million - $10.9 Million	35,308 Added 140.57%	60,425 $0
Q2 2018 Aug 10, 2018	BUY	$245.65 - $309.75 $5.83 Million - $7.36 Million	23,747 Added 1733.36%	25,117 $0
Q1 2018 May 11, 2018	SELL	$213.2 - $261.85 $10.3 Million - $12.6 Million	-48,224 Reduced 97.24%	1,370 $346,000
Q4 2017 Feb 09, 2018	SELL	$186.1 - $220.45 $8.93 Million - $10.6 Million	-47,985 Reduced 49.18%	49,594 $10.7 Million
Q3 2017 Nov 09, 2017	BUY	$164.9 - $187.15 $16.1 Million - $18.3 Million	97,579	97,579 $18.1 Million

Others Institutions Holding ICUI

# of Institutions

275

Shares Held

24.1M

Call Options Held

28.3K

Put Options Held

35.5K

View Full List

About ICU MEDICAL INC

Ticker ICUI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 23,899,400
Market Cap $4.33B
Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...

More about ICUI

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account